Ocular Therapeutix (0OT) Ownership - Who Owns Ocular Therapeutix?
Ocular Therapeutix (0OT) Ownership Overview
- 2.72% Insiders
- 21.38% Mutual Funds
- 2.81% Other Institutional Investors
- 12.48% ETFs
- 60.60% Public Companies and Individual Investors
The ownership structure of Ocular Therapeutix (DE:0OT) stock is a mix of institutional, retail, and individual investors. Approximately 36.68% of the company’s stock is owned by Institutional Investors, 2.72% is owned by Insiders, and 60.60% is owned by Public Companies and Individual Investors.
The ownership structure of Ocular Therapeutix (DE:0OT) stock is a mix of institutional, retail, and individual investors. Approximately 36.68% of the company’s stock is owned by Institutional Investors, 2.72% is owned by Insiders, and 60.60% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Aug 25, 2026 | Sanjay Nayak | $20,450 | |
| Aug 25, 2026 | Pravin Dugel | $233,160 | |
| Jun 04, 2026 | Nadia Waheed | $122,628 | |
| May 27, 2026 | Peter Kaiser | $24,329 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Graham Capital Management, L.p. | €200,358 | |
| Dec 31, 2025 | Farallon Capital Management, L.l.c. | €218,520 | |
| Dec 31, 2025 | Woodline Partners Lp | €20,226,891 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Mt. Vernon Street Trust | 15,016,115 | Institution | 6.84% | 106,839,658 |
| Vanguard | 10,685,390 | Institution | 4.87% | 76,026,550 |
| Ishares | 9,034,136 | Institution | 4.11% | 64,277,878 |
| Vanguard Index Funds | 8,620,272 | Institution | 3.93% | 61,333,235 |
| Pravin Dugel | 3,270,332 | Insider | 1.49% | 23,268,412 |
| Fidelity Select Portfolios | 2,610,252 | Institution | 1.19% | 18,571,943 |
| Fidelity Salem Street Trust | 2,488,622 | Institution | 1.13% | 17,706,546 |
| Tiaa-cref Funds | 2,234,454 | Institution | 1.02% | 15,898,140 |
| Dfa | 1,922,981 | Institution | 0.88% | 13,682,010 |
| T. Rowe Price New Horizons Fund, Inc. | 1,789,197 | Institution | 0.81% | 12,730,137 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Mt. Vernon Street Trust | 15,016,115 | Institution | 6.84% | 106,839,658 |
| Vanguard Index Funds | 8,620,272 | Institution | 3.93% | 61,333,235 |
| Fidelity Select Portfolios | 2,610,252 | Institution | 1.19% | 18,571,943 |
| Fidelity Salem Street Trust | 2,488,622 | Institution | 1.13% | 17,706,546 |
| Tiaa-cref Funds | 2,234,454 | Institution | 1.02% | 15,898,140 |
| T. Rowe Price New Horizons Fund, Inc. | 1,789,197 | Institution | 0.81% | 12,730,137 |
| Fidelity Concord Street Trust | 1,729,797 | Institution | 0.79% | 12,307,506 |
| T. Rowe Price Integrated Equity Funds, Inc. | 1,588,339 | Institution | 0.72% | 11,301,032 |
| T. Rowe Price Health Sciences Fund, Inc. | 1,432,466 | Institution | 0.65% | 10,191,996 |
| Vanguard Scottsdale Funds | 1,416,249 | Institution | 0.64% | 10,076,612 |
FAQ
Who Owns Ocular Therapeutix (DE:0OT)?
According to the latest TipRanks data, approximately 36.68% of the company's stock is held by institutional investors, 2.72% is held by insiders, and 60.60% is held by public companies and individual investors.
What percentage of Ocular Therapeutix (DE:0OT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 36.68% of Ocular Therapeutix (DE:0OT) stock is held by institutional investors: 21.38% by mutual funds, 12.48% by ETFs and 2.81% by other institutional investors.
What percentage of Ocular Therapeutix (DE:0OT) stock is held by retail investors?
According to the latest TipRanks data, approximately 60.60% of Ocular Therapeutix (DE:0OT) stock is held by public companies and individual investors.
Who owns the most shares of Ocular Therapeutix (DE:0OT)?
Fidelity Mt. Vernon Street Trust owns the most shares of Ocular Therapeutix (DE:0OT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.